The Role of Natural Products in Discovery of New Anti-Infective Agents with Emphasis on Antifungal Compounds

Plant Bioactives and Drug Discovery: Principles, Practice, and Perspectives

Volumn , Issue , 2012, Pages 205-239

  Sortino, Maximiliano ^a   Derita, Marcos ^a   Svetaz, Laura ^a   Raimondi, Marcela ^a   Di Liberto, Melina ^a   Petenatti, Elisa ^b   Gupta, Mahabir ^c   Zacchino, Susana ^a  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^b UNIVERSIDAD NACIONAL DE SAN LUIS   (Argentina)

^c UNIVERSIDAD DE PANAMÁ   (Panama)

Author keywords

Active antifungal compounds, mechanism of action; Antifungal compounds to antifungal drugs; Natural products in discovery of new anti infective agents; Natural products, fungal cell wall assembly inhibitors; Synergistic drug discovery within systems biology framework

Indexed keywords

EID: 84880160768     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118260005.ch6     Document Type: Chapter

References (151)

1. World Health Statistics 2009, World Health Organization, Geneva. Available at http://www.who.int/healthinfo/statistics.
2. Mahady, G., Huang, Y., Doyle, B., Locklear, T., Natural products as antibacterial agents. In: Ur-Rahman, A. editor. Studies in Natural Products Chemistry, Vol. 35. Elsevier Science Publishers, Amsterdam, 2008, pp. 423-444.
3. Brown, E., Wright, G. (2005). New targets and screening approaches in antimicrobial drug discovery. Chemical Reviews, 105, 759-774.
4. Detels, R., Emerging infectious diseases. In: Holland, W., Olsen J, Florey C. editors. The Development of Modern Epidemiology. Oxford University Press, Oxford, 2008, pp. 134-145.
5. Heymann D., Emerging and re-emerging infections. In: Detels, R., Beaglehole, R., Lansang, M., Gulliford, M. editors. Oxford Textbook of Public Health. Oxford University Press, Oxford, 2009, pp. 1264-1276.
6. Available at www.who.int/csr/don/2010_10_26
7. Petrikkos, G., Skiada, A. (2007). Recent advances in antifungal chemotherapy, International Journal of Antimicrobial Agents, 30, 108-117.
8. Mathew, B., Nath, M. (2009). Recent approaches to antifungal therapy for invasive mycoses. ChemMedChem, 4, 310-323.
9. Monk, B., Goffeau, A. (2008). Outwitting multidrug resistance to antifungals. Science, 321, 367-369.
10. Weitzman, I., Summerbell, R. (1995). The dermatophytes. Clinical Microbiology Reviews, 8, 240-259.
11. Kontoyiannis, D., Mantadakis, E., Samonis, G. (2003). Systemic mycoses in the immunocompromised host: An update in antifungal therapy. Journal of Hospital Infection, 53, 243-258.
12. Freixa, B., Vila, R., Vargas, L., Lozano, N., Adzet, T., Canĩgueral, S. (1998). Screening for antifungal activity on nineteen Latinoamerican plants. Phytotherapy Research, 10, 427-431.
13. Leonard, W., Belyk, K., Conlon, D., Bender, D., Di Michele, L., Liu, J., Hughes, D. (2007). Synthesis of the antifungal β-1,3-glucan synthase inhibitor CANCIDAS (Caspofungin acetate) from Pneumocandin B. Journal of Organic Chemistry, 72, 2335-2343.
14. Steinberg, T., Wright, E., Oura, M. (1955). A new antifungal antibiotic, amphotericin B. Antibiotics Annual, 3, 566-573.
15. Gold, W., Stout, H., Pagano, J., Donovic, R. (1955). Amphotericins A and B, antifungal antibiotics produced by a streptomycete: I. In vitro studies. Antibiotics Annual, 3, 579-586.
16. Brian, P., Curtis, P., Hemming, H. (1949). A substance causing abnormal developmet of fungal hyphae produced by Penicillium janczewskii Zal: III. Identity of 'curling factor' with griseofulvin. Transactions of the British Mycological Society, 32, 30-33.
17. Peláez, F., Cabello, A., Platas, G., Diez, M., González del Val, A., Martán, I., Vicente, F., Bills, G., Giacobbe, R., Schwartz, R., Onishi, J., Meinz, M., Abbruzzo, G., Flattery, A., Kong, L., Kurtz, M. (2000). The discovery of enfumafungin, a novel antifungal compound produced by an endophytic Hormonema spp biological activity and taxonomy of the producing organisms. Systematics and Applied Microbiology, 23, 333-343.
18. Espinel-Ingroff, A. (2009). Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases:Areviewof the literature (2005-2009). Revista Iberoamericana de Micología, 26, 15-22.
19. Mukherjee, P., Leidich, S., Isham, N., Leitner, I., Ryder, N., Ghannoum, M. (2003). Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine. Antimicrobial Agents and Chemotherapy, 47, 82-86.
20. Tulp, M., Bohlin, L. (2004). Unconventional natural sources for future drug discovery. Drug Discovery Today, 9, 450-458.
21. Harvey, A. (2008). Natural products in drug discovery. Drug Discovery Today, 13, 894-890.
22. Odds, F. (2005). Genomics, molecular targets and the discovery of antifungal drugs. Revista Iberoamericana de Micología, 22, 229-237.
23. Cos, P., Vlietink, A., Vanden Berghe, D., Maes, L. (2006). Anti-infective potential of natural products: how to develop a stronger in vitro "proof-of-concept". Journal of Ethnopharmacology, 106, 290-302.
24. Maregesi, S., Pieters, L., Ngassapa, O., Apers, S., Vigerhoets, R., Cos, P., Vanden Berghe, D., Vlietink, A. (2008). Screening of some Tanzanian medicinal plants from Bunda district for antibacterial, antifungal and antiviral activities. Journal of Ethnopharmacology, 119, 58-66.
25. Rouhi M. (2003). Rediscovering natural products. Chemistry and Engineering News, 81, 77-91.
26. Ríos, J., Recio, M. (2005). Medicinal plants and antimicrobial activity. Journal of Ethnopharmacology, 100, 80-84.
27. Svetaz, L., Zuljan, F., Derita, M., Petenatti, E., Tamayo, G., Cáceres, A., Cechinel-Filho, V., Giménez, A., Pinzón, R., Zacchino, S., Gupta, M. (2010). Value of the ethnomedical information for the discovery of plants with antifungal properties:Asurvey among seven Latin American countries. Journal of Ethnopharmacology, 127, 137-158.
28. Alonso Paz, E., Cerdeiras, M., Fernández, J., Ferreira, F., Moyna, P., Soubes, M., Vázquez, A., Vero, S., Zunino, L. (1995). Screening of Uruguayan medicinal plants for antimicrobial activity. Journal of Ethnopharmacology, 45, 67-70.
29. Portillo, A., Vila, R., Freixa, B., Adzet. T., Canĩgueral, S. (2001). Antifungal activity of Paraguayan plants used in traditional medicine. Journal of Ethnopharmacology, 76, 93-98.
30. Vila, R., Santana, A., Pérez-Roser, R., Valderrama, A., Castelli, M., Mendonca, S., Zacchino, S., Gupta, M.P., Canĩgueral, S. (2010). Composition and biologícal activity of the essentials oil from leaves of Plinia cerrocampanensis, a new source of a-bisabolol. Bioresourse Technology, 10, 2510-2514.
31. Munõz, J., Cruanẽs, A., Vivot, E., Cruanẽs, M., Ruiz, S., Ruiz, C., Salinas, A., Santecchia, C., López, S., Gattuso, S., Zacchino, S. (1998). In vitro antifungal evaluation and studies on mode of action of eight selected species from the Argentinian Flora. Phytomedicine, 585, 389-395.
32. Fenner, R., Sortino, M., Kuze Rates, S., Dall'Agnol, R., Ferraz, A., Bernardi, A., Albring, A., Nör, C., von Poser, G., Schapoval, E., Zacchino, S. (2005). Antifungal activity of some Brazilian Hypericum spp. Phytomedicine, 12, 236-240.
33. Alanís-Garza, B., González-González, G., Salazar-Aranda, R., Waksman de Torres, N., Rivas-Galindo, V. (2007). Screening of antifungal activity of plants, from the northeast of Mexico. Journal of Ethnopharmacology, 114, 468-471.
34. Cáceres, A., López, B., Giron, M., Logemann, H. (1991). Plants used in Guatemala for the treatment of dermatophytic infections: I. Screening for antimycotic activity of 44 plant extracts. Journal of Ethnopharmacology, 31, 263-276.
35. Motsei, M., Lindsey, K., van Staden, J., Jager, A. (2003). Screening of traditionally used South African plants for antifungal activity against Candida albicans. Journal of Ethnopharmacology, 86, 235-241.
36. McCutcheon, A., Ellis, S., Hancock, R., Towers, G. (1994). Antifungal screening of medicinal plants of British Columbian native peoples. Journal of Ethnopharmacology, 44, 157-169.
37. Mistcher, L., Leu, R., Bathala, M., Wu, W., Beal, J. (1972). Antimicrobial agents from higher plants: I. Introduction, rationale and methodology. Lloydia, 35, 157-166.
38. Coelho de Souza, G., Haas, A., von Poser, G., Schapoval, E., Elisabetsky, E. (2004). Ethnopharmacological studies of antimicrobial remedies in the south of Brazil. Journal of Ethnopharmacology, 90, 135-143.
39. Jones, N., Arnason, J., Abou-Zaid, M., Akpagana, K., Sanchez-Vindas, P., Smith, M. (2000). Antifungal activity of extracts from medicinal plants used by First Nations Peoples of eastern Canada. Journal of Ethnopharmacology, 73, 191-198.
40. Cruz, M., Santos, P., Barbosa, A. Jr., de Mélo, D., Alviano, C., Antoniolli, A., Alviano, D., Trindade, R. (2007). Antifungal activity of Brazilian medicinal plants involved in popular treatments of mycoses. Journal of Ethnopharmacology, 111, 409-412.
41. Braga, F., Bouzada, M., Fabri, R., Matus, M., Moreira, F., Scio, E., Coimbra, E. (2007). Antileishmanial and antifungal activity of plants used in traditional medicine in Brazil. Journal of Ethnopharmacology, 111, 396-402.
42. CLSI, Clinical and Laboratory Standards Institute, formerly National Committee for Clinical and Laboratory Standards (NCCLS). Reference methods for broth dilution antifungal susceptibility testing of yeasts and filamentous fungi; Approved Standards. document M27-A2 (2002) and A3 (2008), M38 A (2002) and M38-A2 (2008), Wayne, PA.
43. Cowan, M. (1999). Plant products as antimicrobial agents. Clinical Microbiology Reviews, 12, 564-582.
44. Abad, M., Ansuategui, M., Bermejo, P. (2007). Active antifungal substances from natural sources, ARKIVOC, 7, 116-145.
45. Akendengué, B., Champy, P., Nzamba, J., Roblot, F., F., Loiseau, P., Bories, C. (2009). Antifungal and anthelmintic activities of Cleistopholis patens (Annonaceae). Planta Medica, 75, 1143-1145.
46. Hufford, C., Liu, S., Clark, A. (1987). Anticandidal activity of eupolaridine and onychine alkaloids from Cleistopholis patens. Journal Natural Products, 50, 961-964.
47. Liu, S., Oguntimen, B., Hufford, C., Clark, A. (1990). 3-methoxysampangine, a novel antifungal copyrine alkaloid from Cleistopholis patens. Antimicrobial Agents and Chemotherapy, 34, 529-533.
48. Lago, J. Chaves, M., Cruz, M., Agripino, D., Young, M. (2007). Evaluation of antifungal and DNA-damaging activities of alkaloids from branches of Porcelia macrocarpa. Planta Medica, 73, 292-295.
49. Nenaah, G. (2010). Antibacterial and antifungal activities of (beta)-carboline alkaloids of Peganum harmala L. seeds and their combination effects. Fitoterapia, 81, 779-782.
50. Al-Shamma, A., Drake, S., Flynn, D., Mitscher, L., Park, Y., Rao, G., Simpson, A., Swayze, J., Veysoglu, T., Wu, S. (1981). Antimicrobial agents from higher plants. Antimicrobial agents from Peganum harmala seeds. Journal of Natural Products, 44, 745-747.
51. Rao, G., Zhang, S., Wang, H., Li, Z., Gao, S., Xu, G. (2009). Antifungal alkaloids from the fresh rattan stem of Fibraurea recisa Pierre. Journal of Ethnopharmacology, 123, 1-5.
52. Freile, M., Giannini, F., Sortino, M., Zamora, M., Juarez, A., Zacchino, S., Enriz, R. (2006). Antifungal activity of aqueous extracts and of berberine isolated from Berberis heterophylla. Acta Farmaceutica Bonaerense, 25, 83-88.
53. Slobodníková, L., KoSt'álová, D., Labudová, D., Kotulová, D., Kettmann, V. (2004). Antimicrobial activity of Mahonia aquifolium crude extract and its major isolated alkaloids. Phytotherapy Research, 18, 674-676.
54. Zhang, J., Gao, J., Xu, T., Zhang, X., Ma, Y., Jarussophon, S., Konishi, Y. Antifungal activity of alkaloids from the seeds of Chimonanthus praecox. Chemistry and Biodiversity, 6, 838-845.
55. Simons, V., Morrissey, J., Latijnhouwers, M., Csukai, M. (2006). Dual effects of plant steroidal alkaloids on Saccharomyces cerevisiae. Antimicrobial Agents and Chemotherapy, 50, 2732-2740.
56. Saikia, D., Khanuja, S., Kahol, A., Gupta, S., Kumar, S. (2001). Comparative antifungal activity of essential oils and constituents from three distinct genotypes of Cymbopogon spp. Current Science, 80, 1264-1266.
57. D'Auria, F., Tecca, M., Strippoli, V., Salvatore, G., Battinelli L, Mazzanti G. (2005). Antifungal activity of Lavandula angustifolia essential oil against Candida albicans yeast and mycelial form. Medical Mycology, 43, 391-396.
58. Saddiq, A., Khayyat, S. (2010). Chemical and antimicrobial studies of monoterpene: Citral. Pesticide Biochemistry and Physiology, 98, 89-93.
59. Voda, K., Boh, B., Vrtačnik, M. (2004). A quantitative structure-antifungal activity relationship study of oxygenated aromatic essential oil compounds using data structuring and PLS regression analysis. Journal of Molecular Modeling, 10, 76-84.
60. Ettayebi, K., El Yamani, J., Rossi-Hassani, B. (2000). Synergistic effects of nisin and thymol on antimicrobial activities in Listeria monocytogenes and Bacillus subtilis. FEMS Microbiology Letters, 183, 191-195.
61. Ultee, A., Kets, E., Smid, E. (1999). The phenolic hydroxyl group of carvacrol is essential for action against the food-borne pathogen Bacillus cereus. Applied Environment Microbiology, 65, 4606-4610.
62. Helander, I., Alakomi, H., Latva-Kala, K., Mattila-Sandholm, T., Pol, I., Smid, E., Gorris, L., von Wright, A. (1998). Characterization of the action of selected essential oil components on Gram-negative bacteria. Journal of Agricultural and Food Chemistry, 46, 3590-3595.
63. Kim, J., Marshall, M., Wei, C. (1995). Antibacterial activity of some essential oil components against five foodborne pathogens. Journal of Agricultural and Food Chemistry, 43, 2839-2845.
64. Zemek, J., Valent, M., Pódová, M., Košíková, B., Joniak, D. (1987). Antimicrobial properties of aromatic compounds of plant origin. Folia Microbiologica, 32, 421-425.
65. Boonchird C., Flegel T. (1982). In vitro antifungal activity of eugenol and vanillin against Candida albicans and Cryptococcus neoformans. Canadian Journal of Microbiology, 28, 1235-1241.
66. Lee, S., Lee, J., Lunde, C., Kubo, I. (1999). In vitro antifungal susceptibilities of Candida albicans and other fungal pathogens to polygodial, a sesquiterpene dialdehyde. Planta Medica, 65, 204-208.
67. Almeida T., Lacerda Ribeiro, F., Kloos, H., Zani C. (2001). Polygodial, the fungitoxic component from the Brazilian medicinal plant Polygonum punctatum, Memórias do Instituto Oswaldo Cruz, 96, 831-833.
68. Malheiros, A., Cechinel Filho, V., Schmitt, C., Yunes, R., Escalante, A., Svetaz, L., Zacchino, S., Delle Monache F. (2005). Antifungal activity of drimane sesquiterpenes from Drimys brasiliensis using bioassay-guided fractionation. Journal of Pharmacy and Pharmaceutical Sciences, 8, 335-339.
69. Derita, M., Leiva M., Zacchino, S. (2009). Influence of plant part, season of collection and content of the main active constituent, on the antifungal properties of Polygonum acuminatum Kunth. Journal of Ethnopharmacology, 124, 377-383.
70. Giesbrecht, A., Davino, S., Nassis, C., Young, M., Lopes, J., Rodrigues, D., Vichnewski, Nasi, A., Dias, D., López, J. (1990). Antimicrobial activity of sesquiterpene lactones. Química Nova, 13, 312-314.
71. Erasto, P., Grierson, D., Afolayan, A. (2006). Bioactive sesquiterpene lactones from the leaves of Vernonia amygdalina. Journal of Ethnopharmacology, 106, 117-120.
72. Portillo, A., Vila, R., Freixa, B., Ferro, E., Parella, T., Casanova, J., Canĩgueral, S. (2005). Antifungal sesquiterpene from the root of Vernonanthura tweedieana. Journal of Ethnopharmacology, 106, 49-52.
73. Djeddi, S., Karioti, A., Sokovic, M., Stojkovic, D., Seridi, R., Skaltsa, H. (2007). Minor sesquiterpene lactones from Centaurea pullata and their antimicrobial activity. Journal of Natural Products, 70, 1796-1799.
74. Yang, C., Zhang, Y., Jacob, M., Khan, S., Zhang, Y., Li., X. (2006). Antifungal activity of C-27 steroidal saponins. Antimicrobial Agents and Chemotherapy, 50, 1710-1714.
75. Sparg, S., Light, M., van Staden, J. (2004). Biological activities and distribution of plant saponins. Journal of Ethnopharmacology, 94, 219-243.
76. Favel, A., Steinmetz, M., Regli, P., Vidal-Ollivier, E., Elias, R., Balansard, G. (1994). In vitro antifungal activity of triterpenoid saponins. Planta Medica, 60, 50-53.
77. Escalante, A., Santecchia, C., López, S., Gattuso, M., Gutiérrez, A., Delle Monache, F., González Sierra, M., Zacchino, S. (2002). Isolation of antifungal saponins from Phytolacca tetramera, an Argentinean species in critic risk. Journal of Ethnopharmacology, 82, 29-34.
78. Di Liberto, M., Svetaz, L., Furlán, R., Zacchino, S., Delporte, C., Novoa, M., Asencio, M., Cassels, B. (2010). Antifungal activity of saponin-rich extracts of Phytolacca dioica L. and of the sapogenins obtained through hydrolysis. Natural Products Communications, 5, 1013-1018.
79. Sautour, M., Mitaine-Offer, A.-C., Miyamoto, T., Dongmo, A., Lacaille-Dubois, M. (2004). Antifungal steroid saponins from Dioscorea cayanensis. Planta Medica, 70, 90-92.
80. He, X., Moceck, U., Floss, H., Cáceres, A., Girón, L., Buckley, H., Cooney, G., Manns, J., Wilson, B. (1994). An antifungal compound from Solanum nigrescens. Journal of Ethnopharmacology, 43, 173-177.
81. Zamilpa, A., Tortoriello, J., Navarro, V., Delgado, G., Alvarez, L. (2002). Five new steroidal saponins from Solanum chrysotrichum leaves and their antimycotic activity. Journal of Natural Products, 65, 1815-1819.
82. Silva, I., Raimondi, M., Zacchino, S., Cechinel-Filho, V., Noldin, V., Rao, V., Silva, R., Martins, D. (2010). Evaluation of the antifungal activity and mode of action of Lafoensia pacari St. Hill. (Lythraceae) stem bark extracts, fractions and ellagic acid. Brazilian Journal of Pharmacognosy, 20, 422-428.
83. Kurdelas, R., Tapia, A., Lima, B., Feresin, G., González Sierra, M., Rodríguez, M., Zacchino, S., Enriz, R., Freile, M. (2010). Antifungal activity of extracts and prenylated coumarins isolated from Baccharis darwinii Hook & Arn. (Asteraceae), Molecules, 15, 4898-4907.
84. Pacciaroni, A., Gette, M., Derita, M., Ariza Espinar, L., Gil, R., Zacchino, S., Silva, G. (2008). Antifungal activity of Heterothalamus alienus metabolites. Phytotherapy Research, 22, 524-528.
85. Schmeda-Hirschmann, G., Tapia, A., Feresin, G., Zacchino, S., Sortino, M., Pertino, M., Rojas, A. (2008). A new antifungal and antiprotozoal depside from the Andean lichen Protousnea poepigii. Phytotherapy Research, 22, 349-355.
86. Agüero, M., González Sierra, M., Lima, B., Svetaz, L., Sánchez, M., Zacchino, S., Feresin, G., Schmeda-Hirschmann, G., Palermo, J., Wunderlin, D., Tapia, A. (2010). Argentinean propolis from Zuccagnia punctata Cav. exudates: Phytochemical characterization and antifungical activity. Journal of Agricultural and Food Chemistry, 58, 194-201.
87. Zacchino, S., Rodríguez, G., Pezzenati, G., Orellana, G., Enriz, R., González Sierra, M. (1997). In vitro evaluation of antifungal properties of neolignans 8.O.40. Journal of Natural Products, 60, 659-662.
88. Vicente, F., Basilio, A., Cabello, A., Peláez, F. (2003). Microbial natural products as a source of antifungals. Clinical Microbology and Infectious Diseases, 9, 15-32.
89. Strobel, G, Daisy, B., Castillo, Harper, J. (2004). Natural products from endophytic microorganisms. Journal of Natural Products, 67, 257-268.
90. Mayer, A. Rodríguez, A., Berlinck, R., Hamann, M. (2009). Marine pharmacology in 2005-6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action. Biochimica Biophysica Acta, 1790, 283-308.
91. Sionov, E., Roth, D., Sandovsky-Losica, H., Kashman, Y., Rudi, A., Chill, A., Berdicevsky, I., Segal, E. (2005). Antifungal effect and possible mode of activity of a compound from the marine sponge Dysidea herbacea. Journal of Infection, 50, 453-460.
92. Pettit, R., McAllister, S., Pettit, G., Herald, C., Johnson, M., Cichacz, Z. (1998). Abroadspectrum antifungal from the marine sponge Hyrtios erecta. International Journal of Antimicrobial Agents, 9, 147-152.
93. Kumar, R., Chaturvedi, A., Shukla, P., Lakshmi, V. (2007). Antifungal activity in triterpene glycosides from the sea cucumber Actinopyga lecanora. Bioorganic and Medicinal Chemistry Letters, 17, 4387-4391.
94. Yuan, W., Yi, Y., Tang, R., Wang, Z., Sun, G., Xue, M., Zhang, W., Tang, H. (2009). Antifungal triterpene glycosides from the sea cucumber Holothuria (Microthele) axiloga. Planta Medica, 75, 647-653.
95. Encarnación, R., Murillo, I., Christophersen, C., Chan-Bacab, M., García, R., Zacchino, S. (2006) Leishmanicidal, antifungal, and cytotoxic activity of triterpenoid glycosides isolated from the sea cucumber Neothyone gibbosa. Natural Products Communications, 1, 541-547.
96. Yuan, W., Yi, Y., Tang, H., Liu, B., Wang, Z., Sun, G., Zhang, W., Li, L. (2009). Antifungal triterpene glycosides from the sea cucumber Bohadschia marmorata. Planta Medica, 75, 168-173.
97. Liu, X., Ashforth, E., Ren, B., Song, F., Dai, H., Liu, M., Wang, J., Xie, Q., Zhang, L. (2010). Bioprospecting microbial natural products libraries from the marine environment for drug discovery. Journal of Antibiotics, 63, 415-422.
98. Fusetani, N. (2010). Antifungal peptides in marine invertebrates. Invertebrate Survival Journal, 7, 53-66.
99. Barrett, D. (2002). From natural products to clinically useful antifungals. Biochimica Biophysica Acta, 1587, 224-233.
100. Wagner, H., Ulrich-Merzenich, G. (2009). Synergy research. Approaching a new generation of phytopharmaceuticals. Phytomedicine, 16, 97-110.
101. Ulrich-Merzenich, G., Wagner, H., Panek, D., Zeitler, H., Wagner, H., Vetter, H. (2009). New perspectives for synergy research with the "omic"-technologies. Phytomedicine, 16, 495-508.
102. Odds, F. (2003). Synergy, antagonism and what the chequerboard puts between them. Journal of Antimicrobial Chemotherapy, 52, 1-1.
103. Houghton, P., Synergy and polyvalence: Paradigms to explain the activity of herbal products. In: Houghton, P., Mukherjee, P. editors. Evaluation of Herbal Medicine Products. Pharmaceutical Press, London, 2009, pp. 85-94.
104. Berembaum, M. (1989). What is synergy? Pharmacological Reviews, 41, 93-141.
105. Biavatti, M. (2009). Synergy, a new paradigm, for pharmacotherapy. Brazilian Journal of Pharmaceutical Sciences, 45, 371-378.
106. Borisy, A., Elliot, P., Hurst, M., Lehar, M., Price, R., Serbedzija, G., Zimmermann, G., Foley, M., Stockwell, B., Keith, C. (2003). Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences, 100, 7977-7982.
107. Carpinella, M., Giorda, L., Palacios, S. (2003). Antifungal effects of different extracts from Melia azedarach L. on phytopathogenic fungi and their isolated active components. Journal of Agricultural and Food Chemistry, 51, 2506-2511.
108. Carpinella, M., Ferrayoli, C., Palacios, S. (2005). Antifungal synergistic effect of scopoletin, a hydroxycoumarin isolated from Melia azedarach L. fruits. Journal of Agricultural and Food Chemistry, 53, 2922-2927.
109. Himejima, M., Kubo, I. (1992). Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial. Journal of Natural Products, 55, 620-625.
110. Kubo, I., Muroi, H., Himejima, M. (1993). Combination effects of antifungal nagilactones against C. albicans and two other fungi with penylpropanoids. Journal of Natural Products, 56, 220-226.
111. Abdel-Rahman, M., Hegazy, A., Mohsen Sayed, A., Kabiel, H., El-Alfy, T., El-Komy, S. (2010). Study on combined antimicrobial activity of some biologically active constituents from wild Moringa peregrina Forssk. Journal of Yeast and Fungal Research, 1, 15-24.
112. Hemiswarya, S., Kruthiventi, A., Doble, M. (2008). Synergism between natural products and antibiotics against infectious diseases. Phytomedicine, 15, 639-652.
113. Pyun, M., Shin, S. (2006). Antifungal effects of the volatile oils from Allium plants against Trichophyton species and synergism of the oils with ketoconazole. Phytomedicine, 13, 394-400.
114. Shin, S., Kang, C. (2003). Antifungal activity of the essential oils of Agastache rugosa Kuntze and its synergism with ketoconazole. Letters in Applied Microbiology, 36, 111-115.
115. Giordani, R., Trebaux, J., Masi, M., Regli, P. (2001). Enhanced antifungal activity of ketoconazole by Euphorbia characias latex against Candida albicans. Journal of Ethnopharmacology, 78, 1-5.
116. Suresh, B., Dhanaraj, S., Elangosgiram, K., Chinaswammy, K. (1997). Anticandidal activity of Santolina chamaecyparissus volatile oil. Journal of Ethnopharmacology, 55, 151-159.
117. Lee, S., Kin, C. (1999). Selective combination effect of anethole to antifungal activities of miconazole and amphotericin B. Yakhak Hoeji, 43, 228-232.
118. Hirasawa, M., Takada, K. (2004). Multiple effects of green tea catechin on the antifungal activity of antimycotics against Candida albicans. Journal of Antimicrobial Chemotherapy, 53, 225-229.
119. Ogita, A., Tanaka, T. (2009). Enhancement of the fungicidal activity of Amphotericin B by allicin: Effects on intracellular ergosterol trafficking. Planta Medica, 75, 222-226.
120. Mahboubi, M., Ghazian Bidgoli, F. (2010). In vitro synergistic efficacy of combination of amphotericin B with Myrtus communis essential oil against clinical isolates of Candida albicans. Phytomedicine, 17, 771-774.
121. Giordani, R., Gachon, C., Buc, J., Regli, P., Jacob, J. (1999). Antifungal action of Hevea brasiliensis latex. Its effect in combination with fluconazole on Candida albicans growth. Mycoses, 42, 465-474.
122. Quan, H., Cao, Y.-Y., Xu, Z., Zhao, J., Gao, P., Qin, X., Jiang, Y. (2006). Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole. Antimicrobial Agents and Chemotherapy, 50, 1096-1099.
123. Zhang, L., Yan, K., Zhang, Y., Huang, R., Bian, J., Zheng, Ch., Sun, H., Chen, Z., Sun, N., An, R., Min, F., Zhao, W., Zhuo, Y., You, J., Song, Y., Yu, Z., Liu, Z., Yang, K., Gao, H., Dai, H., Zhang, X., Wang, J., Fu, C., Pei, G., Liu, J., Zhang, S., Goodfellow, M., Jiang, Y., Kuai, J., Zhou, G., Chen, X. (2007). High throughput synergy screening identifies microbial metabolites and antiviral activities. Proceedings of the National Academy of Sciences, 104, 4606-4611.
124. Groll, A., De Lucca, A., Walsh, T. (1998). Emerging targets for the development of novel antifungal therapeutics. Trends in Microbiology, 6, 117-124.
125. Aoki, Y., Kondoh, M., Nakamura, M., Fujii, T., Yamazaki, T., Shimada, H., Arisawa, M. (1994). A new methionine antagonist that has antifungal activity: Mode of action. Journal of Antibiotics, 47, 909-916.
126. Wu, X., Chang, W., Cheng, A., Sun, L., Lou, H. (2010). Plagiochin E, an antifungal active macrocyclic bis, induced apoptosis in Candida albicans through a metacaspase-dependent apoptotic pathway. Biochimica Biophysica Acta, 1800, 439-447.
127. Koehn, F., Kirsch, D., Feng, X., Janso, J., Young, M. (2008). Acell wall-active lipopeptide from the fungus Pochonia bulbillosa. Journal of Natural Products, 71, 2045-2048.
128. Fukushima, Y., Sakagami, Y., Marumo, S. (1993). β-glucan biosynthesis inhibitors isolated from fungi as hyphal malformation inducer. Bioorganic and Medicinal Chemistry Letters, 3, 1219-1222.
129. Castelli, M., Cortés, J., Escalante, A., Bah, M., Pereda-Miranda, R., Ribas, J., Zacchino, S. (2002). In vitro inhibition of 1,3-β-glucan synthase by glycolipids from Convolvulaceous species. Planta Medica, 68, 739-742.
130. Kim, S., Hwang, E., Nam., J., Son, K., Bok, S., Kim, H., Kwan, B. (1999). Inhibition of chitin synthase II by catechins from stem bark of Taxus cuspidata. Planta Medica, 65, 97-98.
131. Jeong., T., Hwang, E., Lee, H., Lee, E., Kim, Y., Min, B., Bae, K., Bok, S., Kim, S. (1999). Chitin synthase II inhibitory activity of ursolic acid, isolated from Crataegus pinnatifida. Planta Medica, 65, 261-263.
132. Hwang, E., Ahn, B., Lee, H., Kim, Y., Lee, K., Bok, S., Kim, Y., Kim, S. (2001). Inhibitory activity for chitin synthase II from Saccharomyces cerevisiae by tannins and related compounds. Planta Medica, 67, 501-504.
133. Ruiz, J., San Blas, G. (2003). Chitin synthesis as a target for antifungal drugs. Current Drugs Target-Infections Disorders, 3, 77-91.
134. Escalante, A., Gattuso, M., Pérez, P. Zacchino, S. (2008). Evidence for the mechanism of action of antifungal Phytolaccoside B isolated from Phytolacca tetramera Hauman. Journal of Natural Products, 71, 1720-1725.
135. López-Villegas, E., Herrera-Arellano, A., Martínez-Rivera, M., Álvarez, L., Cano-Napauseno, M., Marquina, S., Rodríguez-Tovar, A., Tortoriello, J. (2009). Ultraestructural changes on clinical isolates of Trichophyton rubrum, T. mentagrophytes and M. gypseum caused by Solanum chysotrichum saponin SC-2. Planta Medica, 75, 1517-1520.
136. Maget, R., Peypoux, F. (1994). Iturins, a special class of pore-forming lipopeptides: Biological and a physicochemical properties. Toxicology, 87, 151-174.
137. Latoud, C., Peypoux, F., Michel, G. (1987). Action of iturin A, an antifungal antibiotic from Bacillus subtilis, on the yeast Saccharomyces cerevisiae: Modifications of membrane permeability and lipid composition. Journal of Antibiotics, 11, 1588-1595.
138. Laakso, J., Raulli, R., McElhaney, G., Actor, P., Underiner, T., Hotovec, B., Mocek, U., Cihlar, R., Broedel, S. (2003). CT2108A and B: New fatty acids synthase inhibitors as antifungal agents. Journal of Natural Products, 66, 1041-1046.
139. Hecht, S., Berry, D., Mackenzie, L., Busby, R., Nasuti, C. (1992). A strategy for identifying novel, mechanistically unique inhibitors of topoisomerase I. Journal of Natural Products, 55, 401-413.
140. Fostel, J., Montgomery, D., Shen, L. (1992). Characterization of DNA topoisomerase I from Candida albicans as a target for drug discovery. Antimicrobial Agents and Chemotherapy, 36, 2131-2138.
141. Zhang, Z., ElSohly, H., Jacob, M., Pasco, D., Walker, L., Clark, A. (2002). Secreted aspartic proteases from Tovomita krukovii. Planta Medica, 68, 49-54.
142. Allen, J., Davey, H., Broadhust, D., Rowland, J., Oliver, S., Kell, D. (2004). Discrimination of modes of action of antifungal substances by use of metabolic footprinting. Applied and Environmental Microbiology, 70, 6157-6165.
143. Scherer, S., Gene discovery and comparative genomics: Progress and prospects. In: Calderone R.,editor. Candida and Candidiasis. American Society of Microbiology, Washington DC, 2002, pp. 259-265.
144. Denning, D., Anderson, M., Turner, G., Latge, J., Bennett, J. (2002). Sequencing the Aspergillus fumigatus genome. The Lancet Infectious Diseases, 2, 251-253.
145. Schein, J., Tangen, K., Chiu, R., Shin, H., Lengeler, K., McDonald, W., Bosdet, I., Heitman, J., Jones, S., Marra, M., Kronstad, J. (2002). Physical maps for genome analysis of 163 serotype A and D strains of the fungal pathogen Cryptococcus neoformans. Genome Research, 12, 1445-1453.
146. Goffeau, A., Coster, F., Foury, F., Jonniaux, J.-L., Purnelle, B., Talla, E., Tettelin, H., Van Dyck, L. (1997). The yeast genome directory. Nature, 387, 1-105.
147. Spaltman, F., Blunck, M., Ziegelbauer, K. (1999). Computer-aided target selection-prioritizing targets for antifungal drug discovery. Drug Discovery Today, 4, 17-26.
148. Anderson, A. (2003). The process of structure-based drug design. Chemistry and Biology, 10, 787-797.
149. Stahura, F., Bajorath, J. (2001). Bio-and chemo-informatics beyond data management: crucial challenges and future opportunities. Drug Discovery Today, 7, S41-S47.
150. De Backer, M., Van Dijck, P., Luyten W. (2002). Functional genomics approaches for the identification and validation of antifungal drug targets. American Journal of Pharmacogenomics, 2, 113-127.
151. Gordon Foulkes, J. (2002). Elitra Pharmaceuticals: New paradigms for antimicrobial drug discovery. Drug Discovery Today, 7, S12-S15.